Dr. Laura Kruper, MD

Dr. Kruper practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Kruper's NPI, 1548312374, was assigned on January 18, 2007. Dr. Kruper graduated from Perelman School of Medicine - Philadelphia in 2000. Dr. Kruper holds Florida license ME159922.

Dr. Kruper's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Kruper also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Kruper's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Kruper to 1 more breast imaging center, 1 group practice or clinic, 1 hospital outpatient department, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kruper practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kruper's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Kruper is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Kruper's licenses on file in 3 states: Florida, California and Pennsylvania.

Dmand AI lists breast reconstruction, mastectomy and removal of damaged skin or skin graft among the conditions Dr. Kruper treats.

CMS data shows 146 Medicare services from Dr. Kruper across 7 procedure codes in 2024, for 77 Medicare patients. Medicare paid $24,707 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Dr. Kruper in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kruper's median patient age at 64, with 98% women.

In 2024, Dr. Kruper wrote 40 Medicare Part D claims for 28 patients. 98% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $4,809 in total drug cost. In 2016, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kruper for performance year 2024, reported as part of a group. Dr. Kruper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kruper as offering telehealth. CMS counts 62 procedures of mastectomy by Dr. Kruper, more than 96% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 69 papers to Dr. Kruper, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Receptors, Estrogen and Mastectomy. Dr. Kruper has published most often in Ann Surg Oncol. Dr. Kruper's most frequent co-authors are Joanne E. Mortimer, MD, Courtney Anne Vito, MD and John Hosei Yim, MD.

CMS Open Payments shows 21 general payments to Dr. Kruper from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 62% of the total. Elucent Medical paid the most, $7,917.

Dmand AI lists 8 awards for Dr. Kruper, most recently Los Angeles Top Doctors in 2020.

Dr. Kruper graduated from Perelman School of Medicine - Philadelphia in 2000. Dr. Kruper is a member of ACS, ASBS, ASCO and SSO.

Dr. Kruper is in network with 7 carriers, including United Healthcare, Humana and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.